Stock listing

Genovis Ab

Selected listing: GENO · OMXSTO · SEK · SE

Genovis Ab (Stockholm:GENO), Health Technology. Latest release Jul 23, 2026: Genovis AB Interim report January - June 2026.

GENO:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:GENO
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Stockholm
Currency: SEK

About Genovis Ab

Genovis AB is a public company listed on the Swedish market under the ticker GENO. Genovis specializes in developing innovative tools for life science research, focusing on enhancing the efficiency of biopharmaceutical development.

Latest news from Genovis Ab

Genovis AB Interim report January - June 2026

July 23, 2026

Genovis Launches AlligBAITOR™ and Strengthens Its Offering in Advanced Protein Analytics

June 26, 2026

Genovis Acquires KPL — Expanding Its Enzyme Platform with a Proprietary Portfolio of Precision Proteases for Protein Analysis

June 1, 2026

Communiqué from Genovis AB (publ) Annual General Meeting May 18, 2026

May 18, 2026

Genovis Announces Change in Chief Financial Officer Position

May 12, 2026

All Genovis Ab news →

Research Genovis Ab

Genovis Ab company profile

View the public company page for Genovis Ab on 6ix.

Genovis Ab news

Read company news and market updates connected to Genovis Ab.

Genovis Ab investor events

Find investor webinars, events, and replay context for Genovis Ab.